Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID‐19

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China

(2020) Min Wei et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

On the use of corticosteroids for 2019-nCoV pneumonia

(2020) Lianhan Shang et al.   LANCET

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

(2020) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

(2020) Paola Toniati et al.   AUTOIMMUNITY REVIEWS

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

(2020) Yang Yang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Tocilizumab for the treatment of severe coronavirus disease 2019

(2020) Rand Alattar et al.   JOURNAL OF MEDICAL VIROLOGY

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients

(2020) T. Klopfenstein et al.   MEDECINE ET MALADIES INFECTIEUSES

Coronavirus Infections in Children Including COVID-19

(2020) Petra Zimmermann et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Epidemiology of COVID-19 Among Children in China

(2020) Yuanyuan Dong et al.   PEDIATRICS

Effective treatment of severe COVID-19 patients with tocilizumab

(2020) Xiaoling Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

(2020) Camila Rosat Consiglio et al.   CELL

Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia

(2017) Hui Li et al.   Influenza and Other Respiratory Viruses

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

(2017) Rudragouda Channappanavar et al.   Seminars in Immunopathology

Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia*

(2016) Bin Cao et al.   CRITICAL CARE MEDICINE

Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

(2015) Reed A.C. Siemieniuk et al.   ANNALS OF INTERNAL MEDICINE

T cell-mediated immune response to respiratory coronaviruses

(2014) Rudragouda Channappanavar et al.   IMMUNOLOGIC RESEARCH

Cytokine/Chemokine Responses in Activated CD4+ and CD8+ T Cells Isolated from Peripheral Blood, Bone Marrow, and Axillary Lymph Nodes during Acute Simian Immunodeficiency Virus Infection

(2014) C. S. Kenway-Lynch et al.   JOURNAL OF VIROLOGY

Macrophage-Derived Chemokine (CCL22) Is a Novel Mediator of Lung Inflammation Following Hemorrhage and Resuscitation

(2014) Jillian R. Richter et al.   SHOCK